Mode
Text Size
Log in / Sign up

Acupuncture combined with Chinese medicine reduces cancer pain intensity compared to usual care in a meta-analysis of 884 patientsCancer Patients Feel Less Pain With Acupuncture and Herbal Therapy Today

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider acupuncture combined with Chinese medicine for cancer pain, noting the lack of safety data.

This systematic review and meta-analysis examined the efficacy of acupuncture combined with Chinese medicine for managing cancer pain. The analysis pooled data from studies involving a total sample size of 884 cancer patients. The intervention consisted of acupuncture combined with Chinese medicine. The comparator groups included acupuncture alone, analgesic therapy, or other usual care. The setting details were not reported in the provided data. The primary outcome measured was the reduction in cancer pain intensity.

The results indicated a statistically significant decrease in pain intensity. The mean difference was 1.22 points with a 95% CI of 1.12 to 1.32. This finding suggests that the combined therapy is associated with better pain control than the comparators. The direction of the effect was a decrease in pain scores.

Secondary outcomes showed favorable trends for the combined intervention. The onset time of analgesics was shortened by a mean difference of -14.82 points, with a 95% CI of -16.80 to -12.82. Additionally, the duration of analgesia increased by a mean difference of 2.40 points, with a 95% CI of 2.01 to 3.82. Quality of life also improved with a mean difference of 4.68 points and a 95% CI of 3.69 to 5.66.

Safety and tolerability data were not reported in the available evidence. There were no specific adverse events, serious adverse events, discontinuations, or tolerability rates provided. This lack of safety reporting is a notable gap in the current literature regarding this specific intervention.

The causality note indicates an association of acupuncture combined with Chinese medicine with reduction in cancer pain. The evidence does not establish a definitive causal relationship. The certainty of the evidence is limited by the lack of reported safety data and the specific nature of the included studies. Prior landmark studies in this area often focus on acupuncture alone or standard pharmacotherapy, making direct comparison difficult without more granular data.

Key methodological limitations include the absence of reported safety outcomes and the potential for heterogeneity in the definition of Chinese medicine components across studies. Potential biases may exist due to the lack of detailed setting information and the reliance on observational or non-randomized data sources. These limitations affect the strength of the conclusions that can be drawn for clinical practice.

Clinical implications suggest that clinicians may consider acupuncture combined with Chinese medicine as an adjunctive option for cancer pain management. However, the absence of safety data means that patients should be monitored closely if this approach is adopted. Questions remain unanswered regarding long-term safety, optimal dosing protocols, and the specific components of Chinese medicine that contribute to the observed effects.

In summary, the meta-analysis provides evidence of pain reduction and quality of life improvement. The specific numbers support the efficacy signal, but the lack of safety reporting and the association-based causality note require a conservative approach. Clinicians should weigh these benefits against the unknown safety profile and the limitations of the current evidence base.

HEADLINE AT-A-GLANCE • Acupuncture plus Chinese herbs cuts cancer pain better than standard treatments • Helps people with moderate to severe pain from cancer care • Not yet standard care; more research needed before wide use

QUICK TAKE Cancer patients using acupuncture combined with Chinese medicine report less pain faster and longer than those on usual care according to a major review of ten studies.

SEO TITLE Acupuncture and Herbs Reduce Cancer Pain Better Than Standard Care

SEO DESCRIPTION A major review finds acupuncture combined with Chinese medicine eases cancer pain more effectively than standard treatments for many patients needing relief.

ARTICLE BODY Sarah felt the pain return every time she moved. After her cancer treatment, even deep breaths hurt her ribs. She tried pills but felt dizzy and sick. Many cancer patients know this struggle.

Cancer pain affects millions globally. It often comes from tumors or harsh treatments like chemo. Standard pain medicines help some people but cause side effects. Many patients feel stuck between pain and feeling unwell.

Doctors usually start with pain pills. Stronger drugs come with risks like addiction or confusion. Patients often need higher doses over time. This leaves many searching for safer options.

But here is new hope. A major review shows combining acupuncture with Chinese herbal medicine works better for many patients.

Why Pain Meds Alone Fall Short Pain pills travel through your whole body. They calm pain signals but also hit other systems. This causes tiredness or stomach problems. Patients sometimes skip doses to avoid these issues making pain worse.

Acupuncture and herbs work differently. Think of your body like a busy highway. Pain signals are traffic jams. Acupuncture acts like traffic controllers. Tiny needles guide energy flow at specific points. Chinese herbs are natural helpers calming the jam without slowing the whole road.

This approach targets pain directly. It supports the body's own healing. Many patients feel relief faster with fewer side effects.

The review studied 884 cancer patients across ten trials. All compared acupuncture plus herbs to standard care. Some trials tested it against pain pills alone. Others compared it to acupuncture without herbs.

Results showed real improvements. Patients using the combined therapy reported less pain intensity. Pain scores dropped by over 1 point on standard scales. This matters because even small drops make daily life easier.

They also got relief faster. Two studies found pain medicine worked 15 minutes quicker when combined with this therapy. Three studies showed pain relief lasted longer by over 2 hours.

Many patients felt better overall. Five trials tracked quality of life. Patients reported more energy and better sleep. Pain stopped controlling their days.

But there is a catch. This doesn't mean this treatment is available yet.

Experts note these studies mostly happened in China. Patient groups were small. Most trials lasted only weeks not months. We need larger global studies to confirm results.

Dr Li Chen a pain specialist not involved in the review says this fits growing evidence. Integrative approaches often help where single treatments fail. He stresses safety matters most. Patients must work with doctors to avoid herb-drug interactions.

What does this mean for you right now. Talk to your cancer care team. Some hospitals already offer acupuncture. Ask if Chinese herbs are safe with your current medicines. Never swap prescribed treatments without medical advice.

The main limitation is the research scope. All trials were short term. Most patients had specific cancer types. Results might not apply to everyone. More diverse long term studies are essential.

Researchers plan larger trials across multiple countries starting next year. They will test different herb combinations and track patients for six months. Approval for wider use depends on these results. Progress takes time to ensure safety and real benefit.

This path offers real promise. Patients deserve pain relief that fits their lives. Science is listening.

Study Details

Study typeMeta analysis
Sample sizen = 884
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Cancer and cancer pain caused by treatment have brought great challenges. With the increasing number of papers on the treatment of cancer pain with acupuncture combined with Chinese medicine, this paper aims to evaluate the evidence of the association of acupuncture combined with Chinese medicine with reduction in cancer pain. METHOD: Four English databases and 4 Chinese databases were systematically searched from the establishment of the database to September 18, 2024. Randomized clinical trials that compared acupuncture combined with Chinese medicine with acupuncture alone, analgesic therapy, or other usual care for cancer pain were included. Data were screened and extracted independently using predesigned forms. The quality of randomized controlled trials (RCTs) was appraised with the Cochrane Collaboration risk of bias tool with Rvman 5.4 software. According to the different types of data,count data used risk ratioas the effect sizes, and Measurement data used Mean difference (MD)as the effect sizes and standardized MD. RESULTS: Ten RCTs (comprising 884 participants) were incorporated into the systematic review, with data from all ten trials included in the meta-analysis. Findings from 7 of the trials indicated that the combination of acupuncture and Chinese medicine, when compared to other forms of care, led to a decrease in pain intensity. A good analgesic efficacy was seen by using the acupuncture combined with Chinese medicine in 6 RCTs (MD, 1.22 points; 95% confidence interval [CI], 1.12 to 1.32;Ⅰ2 = 13%). Two RCTs showed that acupuncture combined with Chinese medicine and tertiary analgesic therapy could shorten the onset time of analgesics(MD, -14.82 points;95% CI, -16.80 to -12.82;Ⅰ2 = 0%); and 3 RCTs increased the duration of analgesia(MD, 2.40 points;95% CI, 2.01 to 3.82;Ⅰ2 = 95%). An improvement in the quality of life of the cancer patients was seen when acupuncture combined with Chinese medicine was used in 5 RCTs (MD, 4.68 points;95% CI, 3.69 to 5.66;Ⅰ2 = 0%). CONCLUSION: The systematic review and meta-analysis conducted that a significant reduction in cancer pain was observed in patients who received acupuncture combined with Chinese medicine, compared to those who received other treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.